The table below summarizes the Tier 1 and Tier 2 performance goals for real-time PMA supplements. Performance goals are applied to the MDUFA cohort submissions.
|Goal||Tier||Review Time||Performance Level|
FY 2008 – FY 2012 Submissions
|Issue a decision for real-time PMA supplements||1||60 days||80% on time|
|2||90 days||90% on time|
The number of real-time PMA supplement MDUFA cohort submissions increased by almost one-fifth from FY 2008 to FY 2009 (see corresponding graph and table).
Real-Time PMA Supplements
|Type||FY 05||FY 06||FY 07||FY 08||FY 09|
|MDUFA Cohort Submissions*||--||--||--||241†||285|
* Workload for real-time PMA supplements was not reported from FY 2005 through FY 2007 and not required under MDUFMA I.
† FY 2008 number was updated to reflect a correction to the FY 2008 MDUFA Performance Report.
As of September 30, 2009, performance data was available for all (241 of 241) of real-time PMA supplement FY 2008 submissions and almost nine-tenths (250 of 285) of FY 2009 submissions (see table below).
- FDA completed 92 percent (222 of 241) of submissions on time and exceeded the Tier 1 performance goal for FY 2008. FDA met the Tier 1 review-time goal for 227 of 250 submissions in FY 2009. With submissions pending within goal, FDA has the potential to exceed the Tier 1 performance goal for FY 2009.
- FDA met the Tier 2 review-time goal for 234 of 240 submissions in FY 2008 and 237 of 250 submissions in FY 2009. With submissions pending within goal, FDA will exceed the Tier 2 performance goal for FY 2008 and has the potential to exceed the Tier 2 performance goal for FY 2009.
|Fiscal Year||Cohort Closed||Received||Pending|
|Overdue||On Time||Percent |
|Issue a decision for real-time PMA supplements||1||Issue 80% within |
|2||Issue 90% within |
Next page: 510(k) Premarket Notifications